Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Absence of TERT promoter mutations in primary melanocytic tumours of the central nervous system.

Gessi M, van de Nes J, Griewank K, Barresi V, Buckland ME, Kirfel J, Caltabiano R, Hammes J, Lauriola L, Pietsch T, Waha A.

Neuropathol Appl Neurobiol. 2014 Oct;40(6):794-7. doi: 10.1111/nan.12138. No abstract available.

PMID:
24645797
2.

Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.

Koopmans AE, Ober K, Dubbink HJ, Paridaens D, Naus NC, Belunek S, Krist B, Post E, Zwarthoff EC, de Klein A, Verdijk RM; Rotterdam Ocular Melanoma Study Group.

Invest Ophthalmol Vis Sci. 2014 Aug 26;55(9):6024-30. doi: 10.1167/iovs.14-14901.

PMID:
25159205
3.

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

Koelsche C, Sahm F, Capper D, Reuss D, Sturm D, Jones DT, Kool M, Northcott PA, Wiestler B, Böhmer K, Meyer J, Mawrin C, Hartmann C, Mittelbronn M, Platten M, Brokinkel B, Seiz M, Herold-Mende C, Unterberg A, Schittenhelm J, Weller M, Pfister S, Wick W, Korshunov A, von Deimling A.

Acta Neuropathol. 2013 Dec;126(6):907-15. doi: 10.1007/s00401-013-1195-5. Epub 2013 Oct 24.

4.

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.

Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K.

Acta Neuropathol. 2013 Aug;126(2):267-76. doi: 10.1007/s00401-013-1141-6. Epub 2013 Jun 14.

PMID:
23764841
5.

TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases.

Jangard M, Zebary A, Ragnarsson-Olding B, Hansson J.

Melanoma Res. 2015 Jun;25(3):185-8. doi: 10.1097/CMR.0000000000000148.

PMID:
25746036
6.

TERT promoter mutation is uncommon in acral lentiginous melanoma.

Liau JY, Tsai JH, Jeng YM, Chu CY, Kuo KT, Liang CW.

J Cutan Pathol. 2014 Jun;41(6):504-8. doi: 10.1111/cup.12323. Epub 2014 Apr 2.

PMID:
24588324
7.

Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.

Heidenreich B, Nagore E, Rachakonda PS, Garcia-Casado Z, Requena C, Traves V, Becker J, Soufir N, Hemminki K, Kumar R.

Nat Commun. 2014 Feb 26;5:3401. doi: 10.1038/ncomms4401.

PMID:
24569790
8.

Frequency of TERT promoter mutations in human cancers.

Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, da Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simões M, Lima J, Máximo V, Soares P.

Nat Commun. 2013;4:2185. doi: 10.1038/ncomms3185.

PMID:
23887589
9.

[Tert promoter mutations in melanoma: not only the MAP-kinase pathway].

Dereure O.

Ann Dermatol Venereol. 2013 Jun-Jul;140(6-7):487-8. doi: 10.1016/j.annder.2013.04.071. Epub 2013 May 15. French. No abstract available.

PMID:
23773757
10.

Melanomas of unknown primary frequently harbor TERT-promoter mutations.

Egberts F, Krüger S, Behrens HM, Bergner I, Papaspyrou G, Werner JA, Alkatout I, Haag J, Hauschild A, Röcken C.

Melanoma Res. 2014 Apr;24(2):131-6. doi: 10.1097/CMR.0000000000000048.

PMID:
24463461
11.

TERT promoter mutations in primary and secondary glioblastomas.

Nonoguchi N, Ohta T, Oh JE, Kim YH, Kleihues P, Ohgaki H.

Acta Neuropathol. 2013 Dec;126(6):931-7. doi: 10.1007/s00401-013-1163-0. Epub 2013 Aug 17.

PMID:
23955565
12.

TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas.

Arita H, Narita Y, Takami H, Fukushima S, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Shibui S, Ichimura K.

Acta Neuropathol. 2013 Dec;126(6):939-41. doi: 10.1007/s00401-013-1203-9. Epub 2013 Oct 31. No abstract available.

PMID:
24174165
13.

Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles.

Koelsche C, Hovestadt V, Jones DT, Capper D, Sturm D, Sahm F, Schrimpf D, Adeberg S, Böhmer K, Hagenlocher C, Mechtersheimer G, Kohlhof P, Mühleisen H, Beschorner R, Hartmann C, Braczynski AK, Mittelbronn M, Buslei R, Becker A, Grote A, Urbach H, Staszewski O, Prinz M, Hewer E, Pfister SM, von Deimling A, Reuss DE.

Brain Pathol. 2015 Mar;25(2):202-8. doi: 10.1111/bpa.12228. Epub 2014 Dec 15.

PMID:
25399693
14.

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.

Griewank KG, Murali R, Schilling B, Schimming T, Möller I, Moll I, Schwamborn M, Sucker A, Zimmer L, Schadendorf D, Hillen U.

PLoS One. 2013 Nov 18;8(11):e80354. doi: 10.1371/journal.pone.0080354. eCollection 2013.

15.

Lack of TERT promoter mutations in melanomas with extensive regression.

de Unamuno Bustos B, Murria Estal R, Pérez Simó G, Oliver Martínez V, Llavador Ros M, Palanca Suela S, Botella Estrada R.

J Am Acad Dermatol. 2016 Mar;74(3):570-2. doi: 10.1016/j.jaad.2015.10.003. No abstract available.

PMID:
26892657
16.

Is it a primary or metastatic melanocytic neoplasm of the central nervous system?: A molecular based approach.

Cornejo KM, Hutchinson L, Cosar EF, Smith T, Tomaszewicz K, Dresser K, Deng A.

Pathol Int. 2013 Nov;63(11):559-64. doi: 10.1111/pin.12107.

PMID:
24274719
17.

The absence of TERT promoter mutations in primary gastric cancer.

Liu T, Liang X, Björkholm M, Jia J, Xu D.

Gene. 2014 May 1;540(2):266-7. doi: 10.1016/j.gene.2014.02.051. Epub 2014 Feb 26. No abstract available.

PMID:
24583168
18.

TERT promoter mutations in familial and sporadic melanoma.

Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R.

Science. 2013 Feb 22;339(6122):959-61. doi: 10.1126/science.1230062. Epub 2013 Jan 24.

19.

Promoting a new brain tumor mutation: TERT promoter mutations in CNS tumors.

Reitman ZJ, Pirozzi CJ, Yan H.

Acta Neuropathol. 2013 Dec;126(6):789-92. doi: 10.1007/s00401-013-1207-5. No abstract available.

20.

TERT promoter mutations associate with fast-growing melanoma.

Nagore E, Heidenreich B, Requena C, García-Casado Z, Martorell-Calatayud A, Pont-Sanjuan V, Jimenez-Sanchez AI, Kumar R.

Pigment Cell Melanoma Res. 2016 Mar;29(2):236-8. doi: 10.1111/pcmr.12441. Epub 2016 Jan 29. No abstract available.

PMID:
26575949

Supplemental Content

Support Center